Portfolio news 0

Artios Pharma

Artios Pharma Bolsters Board of Directors with Appointment of Chris Liu, PhD

First Light Fusion Ltd

First Light Fusion solves major engineering challenge in the design of an Inertial Confinement Fusion pilot power plant

Mission Therapeutics Limited

Mission Therapeutics commences landmark trial of MTX325, a potential disease-modifying treatment for Parkinson’s Disease

Tissue Regenix Group plc

Tissue Regenix Group plc - Final results for the year ended 31 December 2023

Mission Therapeutics Limited

Mission Therapeutics raises £25.2 million to progress clinical candidates in the area of mitophagy

MoA Technology Ltd

Moa Techology - Moa to develop next-gen bioherbicides in new 10-year commercial partnership with Croda

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies and SeqOne partner to support interpretation of nanopore sequencing in clinical use

First Light Fusion Ltd

First Light Fusion becomes the first private fusion company to fire a successful shot on Sandia's 'Z Machine'

Quantum Dice

Quantum Dice And HSBC Collaborate On The Use Of QRNGs To Enhance Financial Monte Carlo Simulations

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Directorate Change